Innovative Biomarkers Enhance Prognosis in Pancreatic Cancer
This invention affects methods and means for the prognosis of survival time in pancreatic cancer patients, particularly in pancreatic ductal adenocarcinoma.
It is based on a developed expression matrix of genes which is then used to deduct the survival time of pancreatic cancer patients using a newly developed bioinformatics algorithm.
Further Information: PDF
GWT-TUD GmbH; FB Sächsische PatentVerwertungsAgentur (SPVA)
Phone: +49 351 25933 120
Contact
Beate-Victoria Ermisch
